Chiesi Hungary Kft.

Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the US, and France, Chiesi’s commitment to create shared value for society as a whole is legally binding and central to company-wide decision-making. As a certified B Corp since 2019, we’re part of a global community of businesses that meet high standards of social and environmental impact. The company aims at becoming net-zero by 2035. With over 85 years of experience, Chiesi is headquartered in Parma (Italy), operates in 30 countries, and counts more than 6,000 employees. The Group’s research and development centre in Parma works alongside 6 other important R&D hubs in France, the US, Canada, China, the UK, and Sweden. For further information please visit www.chiesi.com. Chiesi Hungary Kft. (prev Torrex Chiesi Kft.) was founded in 1997. Since 2006 it operates as the affiliate of Chiesi Pharmaceuticals GmbH, Vienna, which belongs to Chiesi Farmaceutici S.p.A. located in Parma. Chiesi Hungary Kft. is the local representative organisation of Chiesi providing marketing services for products of Chiesi Group. For further information please visit www.chiesi.hu. We would like to draw your attention to that this channel is only for communication on the activities of Chiesi Hungary Kft. and not for medical help or discussing Chiesi products. In case you would like to reach us with any queries, product quality complaint or adverse reaction, please, contact us via the contact details published at the company’s official website: www.chiesi.hu. Adverse reactions are expected to be primarily reported to the email address of mellekhatas@chiesi.com. Please find our privacy policy here: www.chiesi.hu.